REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Polbionica S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Adhesive Manufacturing | Explosives Manufacturing | All Other Chemical Product and Preparation Manufacturing | Other Industrial Machinery Manufacturing | Wholesale Trade | Retail Trade | Other Information Services | Rental and Leasing Services
Full name: Polbionica S.A. Profile Updated: March 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Polbionica S.A. is based in Poland, with the head office in Zielona Gora. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on January 21, 2025. From the latest financial highlights, Polbionica S.A. reported a net sales revenue drop of 18.6% in 2025. Over the same period, its total assets grew by 108.91%. In 2025, Polbionica S.A.’s net profit margin decreased by 380.93%.

Headquarters
Ul. Nowy Kisielin-A. Wysockiego 1
Zielona Gora; Lubuskie; Postal Code: 66-002

Contact Details: Purchase the Polbionica S.A. report to view the information.

Website: https://polbionica.com/

Basic Information
Registered Capital:
Purchase the Polbionica S.A. report to view the information.
Financial Auditors:
Purchase the Polbionica S.A. report to view the information.
Incorporation Date:
January 21, 2025
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Polbionica S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-18.6%▼
Total Operating Revenue
58.06%▲
Operating Profit
-34.13%▼
EBITDA
-27.5%▼
Net Profit/Loss for the Period
-19.45%▼
Total Assets
108.91%▲
Total Equity
73.93%▲
Operating Profit Margin
-456.13%▼
Net Profit Margin
-380.93%▼
Return on Equity (ROE)
8.74%▲
Debt / Equity
8.75%▲
Quick Ratio
-0.28%▼
Cash Ratio
-0.06%▼

Similar companies

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
 
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
Selvita S.A.
 
Polpharma Biologics S.A.
Siec Badawcza Lukasiewicz - Port Polski Osrodek Rozwoju Technologii
 
Ryvu Therapeutics S.A.
Valueadd Pharma (By Dr. Murpani) sp. k.
 
Labpoint Sp. z o.o.
Vasa Therapeutics Sp. z o.o.
 
Extremo Technologies Sp. z o.o.
Bioactive-Tech Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo